1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 768 Re-directed T cell therapy to control invasive aspergillosis. (10th December 2020) Authors: Bavisi, Karishma; Wurster, Sebastian; Albert, Nathaniel; Neelapu, Sattva; Kontoyiannis, Dimitrios P; Kumaresan, Pappanaicken Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma. (11th September 2015) Authors: Takahashi, Koichi; Sivina, Mariela; Hoellenriegel, Julia; Oki, Yasuhiro; Hagemeister, Fredrick B.; Fayad, Luis; Romaguera, Jorge E.; Fowler, Nathan; Fanale, Michelle A.; Kwak, Larry W.; Samaniego, Felipe; Neelapu, Sattva; Xiao, Lianchun; Huang, Xuelin; Kantarjian, Hagop; Keating, Michael J.; Wier... Journal: British journal of haematology Issue: Volume 171:Number 5(2015:Dec.) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies. Issue 1 (2nd January 2022) Authors: Wilson, Nathaniel R.; Bover, Laura; Konopleva, Marina; Han, Lina; Neelapu, Sattva; Pemmaraju, Naveen Journal: Leukemia & lymphoma Issue: Volume 63:Issue 1(2022) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function. Issue 2 (December 2015) Authors: Chu, Fuliang; Neelapu, Sattva Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era. Issue 2 (28th January 2020) Authors: Hu, Bei; Nastoupil, Loretta J.; Loghavi, Sanam; Westin, Jason R.; Thakral, Beenu; Fayad, Luis E.; Hagemeister, Fredrick; Neelapu, Sattva; Samaniego, Felipe; Lee, Hun J.; Wang, Michael L.; Fanale, Michelle; Fowler, Nathan; Oki, Yasuhiro Journal: Leukemia & lymphoma Issue: Volume 61:Issue 2(2020) Page Start: 328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patients. Issue 6 (17th April 2020) Authors: Zhao, Shuangtao; Kanagal‐Shamanna, Rashmi; Navsaria, Lucy; Ok, Chi Young; Zhang, Shaojun; Nomie, Krystle; Han, Guangchun; Hao, Dapeng; Hill, Holly A.; Jiang, Changying; Yao, Yixin; Nastoupil, Loretta; Westin, Jason; Fayad, Luis; Nair, Ranjit; Steiner, Raphel; Ahmed, Sairah; Samaniego, Felipe; Iye... Journal: American journal of hematology Issue: Volume 95:Issue 6(2020:Jun.) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib. (2nd September 2018) Authors: Jain, Preetesh; Kanagal‐Shamanna, Rashmi; Zhang, Shaojun; Ahmed, Makhdum; Ghorab, Ahmad; Zhang, Liang; Ok, Chi Young; Li, Shaoying; Hagemeister, Frederick; Zeng, Dongfeng; Gong, Tiejun; Chen, Wendy; Badillo, Maria; Nomie, Krystle; Fayad, Luis; Medeiros, Leonard J.; Neelapu, Sattva; Fowler, Nathan... Journal: British journal of haematology Issue: Volume 183:Number 4(2018) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma. Issue 12 (3rd May 2018) Authors: Romaguera, Jorge E.; Wang, Michael; Feng, Lei; Fayad, Luis E.; Hagemeister, Frederick; McLaughlin, Peter; Rodriguez, M. Alma; Fanale, Michelle; Orlowski, Robert; Kwak, Larry W.; Neelapu, Sattva; Oki, Yasuhiro; Pro, Barbara; Younes, Anas; Samaniego, Felipe; Fowler, Nathan; Hartig, Kimberly; Valent... Journal: Cancer Issue: Volume 124:Issue 12(2018) Page Start: 2561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗